• Sign up
  • Login

Scheme Profile

ICICI Pru P.H.D Fund (G)

Get detailed information of scheme on investment, NAV, Performance.
AUM ( Cr. )
5,024
Inception Date
13-07-2018
Category
Equity - Sectoral - Pharma

Key Parameters

  • Type
  • OPEN ENDED
  • Minimum Investment ()
  • 5000
  • 52 Week High / Low ()
  • 39.36 (15-Oct-2024) / 25.39 (23-Nov-2023)
  • Incremental Investment ()
  • 1000
  • NAV ()
  • 37.42 ( 0.31) ( 0.84 %)
  • Benchmark
  • BSE Healthcare TRI
  • Entry Load
  • Nil
  • Exit Load
  • 1.00% - If units purchased or switched in from another scheme of the fund are redeemed or switched out within 15 Days from the date of allotment Nil - If units purchased or switched in from another scheme of the fund are redeemed or switched out after 15 Days from the date of allotment
  • Expense Ratio (%)
  • 2.07
  • Maturity Date
  • NA

Portfolio Indicators

  • Portfolio P/E
  • 52.21 times
  • Portfolio P/B
  • 6.82 times
  • Average Maturity
  • -
  • Yield To Maturity
  • -
  • Modified Duration
  • -
  • Turnover Ratio (%)
  • 0.92

Risk Factors

  • Jenson's Alpha
  • 2.73
  • Standard Deviation
  • 4.21
  • Beta
  • 0.89
  • Sharpe
  • 0.55
  • R-Squared
  • 1.00
  • Treynor Factor
  • 0.41

NAV Movement

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

AUM Growth ( Cr.)

  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y

Performance

  • Scheme Name
  • YTD (%)
  • 3 Months (%)
  • 6 Months (%)
  • 1 Year (%)
  • 3 Years (%)
  • 5 Years (%)
  • 10 Years (%)
  • Since Inception
  • BSE Healthcare TRI
  • 10.35
  • -0.51
  • 15.09
  • 48.32
  • 13.19
  • 22.14
  • 13.77
  • -

Company Top 5 Holdings

  [ As on 31 Oct 2024 ] More
  • Company
  • Asset
  • Value( in Cr.)
  • Holdings (%)
  • Sun Pharmaceuticals Industries Ltd
  • Equity
  • 39,00,485
  • 14.35
  • Dr Reddys Laboratories Ltd
  • Equity
  • 35,58,630
  • 9.03
  • Cipla Ltd
  • Equity
  • 26,11,550
  • 8.07
  • Lupin Ltd
  • Equity
  • 10,55,581
  • 4.59
  • Aurobindo Pharma Ltd
  • Equity
  • 16,43,259
  • 4.57

Sector Top 5 Holdings

  [ As on 31 Oct 2024 ] More
  • Sector
  • Value( in Cr.)
  • Holdings (%)
  • Pharmaceuticals
  • 2,96,48,953
  • 76.08
  • Healthcare
  • 1,13,45,829
  • 17.93
  • Insurance
  • 20,19,726
  • 2.33
  • Retail
  • 17,06,776
  • 2.31
  • Chemicals
  • 1,77,422
  • 1.35

Annual Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
YTD 37.47 31.98 10.35 7.34 5,024.00
2023 41.68 31.12 38.35 18.10 3,361.31
2022 -8.28 -9.58 -11.31 2.80 2,513.92
2021 17.63 17.96 20.57 21.69 2,963.80
2020 70.88 65.84 62.19 15.60 2,159.31
2019 4.44 4.22 -3.06 13.79 1,286.90
2018 -1.20 -2.00 -5.45 6.67 1,468.28

Quarterly Performance

Year Return (%) AUM ( in Cr.)
Scheme Return Category Return Benchmark Return Sensex Return
Sep-2024 20.51 19.55 0 0 4,987.49
Jun-2024 5.19 3.76 0 0 4,125.26
Mar-2024 10.95 9.70 10.84 1.91 3,772.32
Dec-2023 11.67 11.42 11.01 10.27 3,361.31

Peer Comparison

<< < 12> >> 

Asset Allocation

Sector Allocation

Quick links

Close